These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13888046)

  • 1. In vivo-inhibition of serotonin synthesis in mouse brain by beta-phenylethylhydrazine, an inhibitor of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    Biochem Pharmacol; 1962 Jan; 11():45-52. PubMed ID: 13888046
    [No Abstract]   [Full Text] [Related]  

  • 2. An effect of monoamine oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    J Neurochem; 1962; 9():299-306. PubMed ID: 13888045
    [No Abstract]   [Full Text] [Related]  

  • 3. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monoamine oxidase inhibitors on the borohydride stabilizable binding of serotonin and tryptamine in brain.
    Ungar F; Callaghan OH
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):191-9. PubMed ID: 877408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition by monoamine oxidase inhibitors of substrate induction of liver tryptophan pyrrolase and increase in brain serotonin].
    Samsonova ML; Oksenkrug GF
    Vopr Med Khim; 1972; 18(2):198-202. PubMed ID: 4679586
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
    Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S
    Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 9. NEW ORALLY ACTIVE MONOAMINE OXIDASE (MAO) INHIBITORS.
    JORI A; BONACCORSI A; VALZELLI L; GARATTINI S
    Life Sci (1962); 1963 Aug; 8():611-7. PubMed ID: 14058510
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 14. THE INITIAL INACTIVATION OF PHENELZINE BY A MONOAMINE OXIDASE-LIKE SYSTEM IN VITRO AND IN VIVO.
    HORITA A
    Br J Pharmacol Chemother; 1965 Feb; 24(1):245-52. PubMed ID: 14302358
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 17. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo.
    Green AL; El Hait MA
    J Pharm Pharmacol; 1980 Apr; 32(4):262-6. PubMed ID: 6103055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE EFFECTS OF PHENELZINE ON SEROTONIN, NORADRENALINE, AND MONOAMINE OXIDASE IN THE RAT.
    MCNEILL JH; RIEDEL BE
    Can J Physiol Pharmacol; 1964 Jan; 42():33-9. PubMed ID: 14324151
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.